全文获取类型
收费全文 | 790篇 |
免费 | 71篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 37篇 |
妇产科学 | 8篇 |
基础医学 | 86篇 |
口腔科学 | 13篇 |
临床医学 | 87篇 |
内科学 | 158篇 |
皮肤病学 | 56篇 |
神经病学 | 52篇 |
特种医学 | 49篇 |
外科学 | 61篇 |
综合类 | 26篇 |
预防医学 | 91篇 |
眼科学 | 6篇 |
药学 | 86篇 |
中国医学 | 1篇 |
肿瘤学 | 40篇 |
出版年
2021年 | 12篇 |
2020年 | 18篇 |
2019年 | 11篇 |
2018年 | 17篇 |
2017年 | 9篇 |
2016年 | 15篇 |
2015年 | 18篇 |
2014年 | 22篇 |
2013年 | 17篇 |
2012年 | 35篇 |
2011年 | 42篇 |
2010年 | 30篇 |
2009年 | 18篇 |
2008年 | 30篇 |
2007年 | 23篇 |
2006年 | 39篇 |
2005年 | 34篇 |
2004年 | 31篇 |
2003年 | 28篇 |
2002年 | 23篇 |
2001年 | 25篇 |
2000年 | 16篇 |
1999年 | 18篇 |
1998年 | 24篇 |
1997年 | 14篇 |
1996年 | 20篇 |
1995年 | 13篇 |
1994年 | 15篇 |
1993年 | 16篇 |
1992年 | 18篇 |
1991年 | 17篇 |
1990年 | 9篇 |
1989年 | 23篇 |
1988年 | 16篇 |
1987年 | 22篇 |
1986年 | 18篇 |
1985年 | 10篇 |
1984年 | 14篇 |
1983年 | 9篇 |
1982年 | 9篇 |
1981年 | 4篇 |
1980年 | 6篇 |
1979年 | 8篇 |
1978年 | 3篇 |
1976年 | 5篇 |
1975年 | 4篇 |
1974年 | 6篇 |
1973年 | 5篇 |
1969年 | 4篇 |
1965年 | 3篇 |
排序方式: 共有868条查询结果,搜索用时 15 毫秒
1.
2.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
3.
4.
5.
6.
7.
8.
A L Clark-Schmidt W R Garnett D R Lowe H T Karnes 《American journal of hospital pharmacy》1990,47(9):2034-2037
The apparent loss of carbamazepine suspension during administration through polyvinyl chloride nasogastric feeding tubes in vitro was studied. Twelve methods of administering carbamazepine suspension (100 mg/5 mL) were tested; the methods differed with respect to nasogastric tube size, presence and type of diluent, and type of flush solution. Undiluted or 50% diluted carbamazepine suspension 200 mg was drawn up in a syringe and forced through adult or pediatric nasogastric feeding tubes. The tubes were immediately flushed twice with 50 mL of sterile water, 0.9% sodium chloride solution, or 5% dextrose solution, by using the same syringe used to administer the suspension. Samples were collected and analyzed for carbamazepine concentration by high-performance liquid chromatography. Each administration method was tested six times, and the results were subjected to analysis of variance. Significant loss of carbamazepine was noted for four of the six methods in which undiluted suspension was administered. In these methods, adult and pediatric tubes were flushed with sterile water or 0.9% sodium chloride. No significant loss of drug occurred for any of the methods involving the use of diluent. Significant losses were associated with diluent and flush solution but not nasogastric tube size. Carbamazepine suspension should be mixed with an equal volume of diluent before being administered through nasogastric feeding tubes. 相似文献
9.
10.
Urethane anesthetized (< 1 .3 g/kg), Sprague-Dawley (SD) rats spontaneously cycled between a cortically desynchronized state (State I) and a cortically synchronized state (State III), which were very similar to awake and slow wave sleep (SWS) states in unanesthetized animals, based on EEG criteria. These low levels of urethane anaesthesia did not cause significant respiratory depression or reductions in sensitivity to hypoxia (10% O2 in nitrogen) or hypercapnia (5% CO2 in air) in rats in either State I or State III. Thus, breathing frequency (fR), tidal volume (VT) and total ventilation (VTOT) all increased on cortical activation in urethane-anaesthetized rats whether breathing air, the hypoxic or the hypercapnic gas mixture, in a manner that was very similar to that observed in unanaesthetized animals. The relative sensitivity to hypoxia was greater in State III than State I, the relative sensitivity to CO2, overall, was equal in both states, State III occurred less often during hypoxia and hypercapnia, and hypoxic, urethane-anaesthetized rats sighed frequently, particularly in State I. This is also similar to the situation seen in unanesthetized rats. Given the similarities seen between urethane anesthetized rats in the present study and literature values for unanesthetized rats, the data suggest that urethane-anaesthetized rats provide a good model system for studying respiratory patterns and chemoreflexes as a function of cortical activation state. 相似文献